货号 | 中文品名 | CAS No. | 别名 |
WT-DM-C22724 | LDN-193189 | 1062368-24-4 | DM-3189 |
WT-DM-C22725 | TAE684 | 761439-42-3 | NVP-TAE684 |
WT-DM-C22728 | IM-12 | 1129669-05-1 | GSK3β Inhibitor XIX |
WT-DM-C22729 | 6-Formylpterin | 712-30-1 | 2-Amino-6-formylpteridin-4-one |
WT-DM-C22731 | NMS-873 | 1418013-75-8 | VCP Inhibitor III |
WT-DM-C22733 | (S)-nitro-Blebbistatin | 856925-75-2 | S-(?)-7-Desmethyl-8-nitro Blebbistatin |
WT-DM-C22734 | PND1186 | 1061353-68-1 | SR 2516 |
WT-DM-C22735 | Metolazone | 17560-51-9 | SR 720-22 |
WT-DM-C22736 | Chk2 Inhibitor II | 516480-79-8 | BML-277 |
WT-DM-C22737 | α-NETA | 31059-54-8 | |
WT-DM-C22738 | EPZ005687 | 1396772-26-1 | |
WT-DM-C22739 | L-α-Aminoadipic Acid | 1118-90-7 | (S)-2-Aminohexanedioic Acid |
WT-DM-C22740 | R-(?)-Deprenyl (hydrochloride) | 14611-52-0 | L-Deprenyl |
WT-DM-C22741 | ISCK03 | 945526-43-2 | c-Kit Inhibitor II |
WT-DM-C22743 | Wiskostatin | 253449-04-6 | |
WT-DM-C22744 | Isofagomine (D-tartrate) | 957230-65-8 | |
WT-DM-C22746 | Fatostatin (hydrobromide) | 298197-04-3 | 125B11 |
WT-DM-C22747 | ERK Inhibitor | 1049738-54-6 | Extracellular Regulated Kinase Inhibitor |
WT-DM-C22748 | Filgotinib | 1206161-97-8 | GLPG0634 |
WT-DM-C22749 | α-Truxillic Acid | 490-20-0 | Gratissimic Acid |
WT-DM-C22750 | Pirinixic Acid Aminothiazole | 1492060-44-2 | |
WT-DM-C22751 | Fluvastatin | 93957-54-1 | NSC 758896 |
WT-DM-C22753 | TZ9 | 1002789-86-7 | |
WT-DM-C22754 | STAT5 Inhibitor | 285986-31-4 | Signal Transducers and Activators of Transcription 5 |
WT-DM-C22755 | Remodelin | 949912-58-7 | |
WT-DM-C22759 | HA-100 (hydrochloride) | 210297-47-5 | C-1 |
WT-DM-C22761 | Z-AEVD-FMK | 1135688-47-9 | Z-Ala-Glu-Val-Asp-Fluoromethyl Ketone |
WT-DM-C22762 | MIF Antagonist | 478336-92-4 | ISO-1 |
WT-DM-C22763 | Skepinone-L | 1221485-83-1 | |
WT-DM-C22764 | O6-Benzylguanine | 19916-73-5 | NSC 637037 |
WT-DM-C22766 | EPZ6438 | 1403254-99-8 | Tazemetostat |
WT-DM-C22767 | OTX015 | 202590-98-5 | HY-15743 |
WT-DM-C22769 | Monoacylglycerol Lipase Inhibitor 21 | 1643657-35-5 | MAGL Inhibitor 21 |
WT-DM-C22770 | Satratoxin G | 53126-63-9 | |
WT-DM-C22771 | SMER3 | 67200-34-4 | SCFMET30 Inhibitor |
WT-DM-C22772 | WDR5-0103 | 890190-22-4 | WD-Repeat Protein 5-0103 |
WT-DM-C22773 | Dutasteride | 164656-23-9 | |
WT-DM-C22774 | Z-Asp-CH2-DCB | 153088-73-4 | Z-Asp-2,6-Dichlorobenzoyloxymethyl Ketone |
WT-DM-C22777 | Irinotecan (hydrochloride hydrate) | 136572-09-3 | |
WT-DM-C22779 | Tofacitinib (citrate) | 540737-29-9 | CP 690,550 |
WT-DM-C22780 | LCK Inhibitor | 213743-31-8 | Lymphocyte-specific Protein Tyrosine Kinase |
WT-DM-C22781 | JZL 184 | 1101854-58-3 | |
WT-DM-C22782 | Methotrexate (hydrate) | 133073-73-1 | Amethopterin |
WT-DM-C22785 | Azathioprine | 446-86-6 | Azamune |
WT-DM-C22787 | Lapatinib | 231277-92-2 | GSK 572016 |
WT-DM-C22788 | (R)-CR8 | 294646-77-8 | |
WT-DM-C22790 | Cediranib | 288383-20-0 | AZD 2171 |
WT-DM-C22791 | AK-7 | 420831-40-9 | |
WT-DM-C22792 | Thiamet G | 1009816-48-1 | |
WT-DM-C22793 | Dasatinib | 302962-49-8 | BMS 354825 |
WT-DM-C22794 | Lestaurtinib | 111358-88-4 | A 154475.0 |
WT-DM-C22795 | (S)-Acenocoumarol | 66556-78-3 | (S)-Acenocoumarin |
WT-DM-C22797 | Mubritinib | 366017-09-6 | TAK-165 |
WT-DM-C22798 | (R)-Acenocoumarol | 66556-77-2 | (R)-Acenocoumarin |
WT-DM-C22799 | Monastrol | 329689-23-8 | (±)-Monastrol |
WT-DM-C22800 | Ruxolitinib | 941678-49-5 | INCB 018424 |
WT-DM-C22802 | Metyrapone | 54-36-4 | NSC 25265 |
WT-DM-C22803 | Canertinib (hydrochloride) | 289499-45-2 | CI-1033 |
WT-DM-C22805 | Rivastigmine (tartrate) | 129101-54-8 | Exelon |
WT-DM-C22808 | Rasagiline | 136236-51-6 | (R)-(+)-Rasagiline |
WT-DM-C22809 | PFI-1 | 1403764-72-6 | PF-06405761 |
WT-DM-C22811 | STK393606 | 355827-05-3 | |
WT-DM-C22814 | Lonidamine | 50264-69-2 | AF 1890 |
WT-DM-C22816 | ZLJ-6 | 1051931-39-5 | |
WT-DM-C22818 | Pyroxamide | 382180-17-8 | |
WT-DM-C22820 | DBZ | 209984-56-5 | Dibenzazepine |
WT-DM-C22821 | JW 618 | 1416133-88-4 | |
WT-DM-C22822 | Zaltoprofen | 74711-43-6 | CN 100 |
WT-DM-C22823 | BIO | 667463-62-9 | 6-Bromoindirubin-3'-oxime |
WT-DM-C22826 | (±)-Blebbistatin | 674289-55-5 | |
WT-DM-C22827 | Pemetrexed (sodium salt hydrate) | 357166-29-1 | |
WT-DM-C22832 | (?)-AS 115 | 926657-43-4 | |
WT-DM-C22833 | Torin 2 | 1223001-51-1 | |
WT-DM-C22834 | S3I-201 | 501919-59-1 | NSC 74859 |
WT-DM-C22836 | EBPC | 4450-98-0 | NSC 229530 |
WT-DM-C22837 | Thiazovivin | 1226056-71-8 | Tzv |
WT-DM-C22838 | Salermide | 1105698-15-4 | |
WT-DM-C22839 | SL 0101-1 | 77307-50-7 | |
WT-DM-C22840 | DMXAA | 117570-53-3 | ASA 404 |
WT-DM-C22841 | Halopemide | 59831-65-1 | NSC 354856 |
WT-DM-C22844 | (+)-Blebbistatin | 1177356-70-5 | (R)-Blebbistatin |
WT-DM-C22845 | W-5 (hydrochloride) | 61714-25-8 | |
WT-DM-C22847 | (–)-Blebbistatin | 856925-71-8 | (S)-Blebbistatin |
WT-DM-C22848 | MS-1020 | 1255516-86-9 | |
WT-DM-C22849 | HA-1100 (hydrochloride) | 155558-32-0 | |
WT-DM-C22851 | Sunitinib (malate) | 341031-54-7 | SU11248 |
WT-DM-C22852 | CI-1040 | 212631-79-3 | PD 184352 |
WT-DM-C22853 | PP1 (Src Inhibitor) | 172889-26-8 | AGL 1872 |
WT-DM-C22855 | PX 12 | 141400-58-0 | |
WT-DM-C22857 | Mirin | 299953-00-7 | |
WT-DM-C22859 | Bucladesine (sodium salt) | 16980-89-5 | DC 2797 |
WT-DM-C22861 | ITF 2357 | 732302-99-7 | |
WT-DM-C22864 | WIN 18,446 | 1477-57-2 | NSC 59354 |
WT-DM-C22865 | Propylthiouracil | 51-52-5 | NSC 6498 |
WT-DM-C22866 | WHI-P131 | 202475-60-3 | Janex 1 |
WT-DM-C22868 | (±)-Rolipram | 61413-54-5 | SB 95952 |
WT-DM-C22869 | C646 | 328968-36-1 | |
WT-DM-C22871 | 2,3-dihydrothieno-Thiadiazole Carboxylate | 152467-47-5 | MTCC |
WT-DM-C22872 | SD 169 | 1670-87-7 | 5-Carbamoylindole |
WT-DM-C22873 | Leflunomide | 75706-12-6 | HW 486 |
WT-DM-C22874 | Amlexanox | 68302-57-8 | AA 673 |
WT-DM-C22875 | TWS119 | 601514-19-6 | |
WT-DM-C22876 | W-7 (hydrochloride) | 61714-27-0 | NSC 683545 |
WT-DM-C22878 | YM-155 | 781661-94-7 | Sepantronium bromide |
WT-DM-C22879 | Meloxicam | 71125-38-7 | UH-AC 62XX |
WT-DM-C22880 | 6-Aminonicotinamide | 329-89-5 | 6-AN |
WT-DM-C22881 | D-NMMA (acetate) | 137694-75-8 | D-NG-monomethyl Arginine Acetate |
WT-DM-C22882 | 2,4-Pyridinedicarboxylic Acid (hydrate) | 207671-42-9 | 2,4-Dicarboxylpyridine |
WT-DM-C22883 | AMP-Deoxynojirimycin | 216758-20-2 | Adamantane-pentyl-dNM |
WT-DM-C22884 | Lonafarnib | 193275-84-2 | Sarasar |
WT-DM-C22886 | Wortmannin | 19545-26-7 | KY 12420 |
WT-DM-C22888 | β-cyano-L-Alanine | 6232-19-5 | BCA |
WT-DM-C22889 | PS-1145 | 431898-65-6 | IKK Inhibitor X |
WT-DM-C22890 | Torin 1 | 1222998-36-8 | |
WT-DM-C22893 | Butyrolactone 3 | 778649-18-6 | |
WT-DM-C22895 | Cilostazol | 73963-72-1 | OPC 13013 |
WT-DM-C22896 | CI-994 | 112522-64-2 | N-Acetyldinaline |
WT-DM-C22898 | Nafamostat (mesylate) | 82956-11-4 | Coahibitor |
WT-DM-C22899 | CPTH2 (hydrochloride) | 2108899-91-6 | |
WT-DM-C22902 | VX-702 | 745833-23-2 | |
WT-DM-C22903 | Propenyl-L-NIO (hydrochloride) | | |
WT-DM-C22909 | DL-Propargyl Glycine (hydrochloride) | 16900-57-5 | PAG |
WT-DM-C22910 | JFD00244 | 96969-83-4 | BML-266 |
WT-DM-C22911 | Anastrozole | 120511-73-1 | Anastrol |
WT-DM-C22912 | Ibudilast | 50847-11-5 | AV 411 |
WT-DM-C22916 | HA-1077 (hydrochloride) | 203911-27-7 | Fasudil |
WT-DM-C22917 | Zinc Protoporphyrin-9 | 15442-64-5 | ZnPPIX |
WT-DM-C22918 | Ethyl-L-NIO (hydrochloride) | 150403-97-7 | L-N5-(1-Iminobutyl)ornithine |
WT-DM-C22919 | Daminozide | 1596-84-5 | Aminozide |
WT-DM-C22920 | Cilostamide | 68550-75-4 | OPC 3689 |
WT-DM-C22923 | FAK Inhibitor 14 | 4506-66-5 | Focal Adhesion Kinase Inhibitor 14 |
WT-DM-C22924 | Vinyl-L-NIO (hydrochloride) | 728944-69-2 | |
WT-DM-C22925 | Lazabemide | 103878-84-8 | Ro 19-6327/000 |
WT-DM-C22927 | Src Kinase Inhibitor I | 179248-59-0 | |
WT-DM-C22928 | INK128 | 1224844-38-5 | MLN0128 |
WT-DM-C22931 | PCI 34051 | 950762-95-5 | |
WT-DM-C22932 | MSDC-0160 | 146062-49-9 | |
WT-DM-C22934 | Lomeguatrib | 192441-08-0 | PaTrin 2 |
WT-DM-C22935 | Acenocoumarol | 152-72-7 | (±)-Acenocoumarin |
WT-DM-C22936 | Stattic | 19983-44-9 | STAT3 Inhibitor V |
WT-DM-C22937 | S14161 | 883046-50-2 | |
WT-DM-C22938 | Dorsomorphin | 866405-64-3 | BML-275 |
WT-DM-C22941 | Teniposide | 29767-20-2 | NSC 122819 |
WT-DM-C22943 | H-8 (hydrochloride) | 113276-94-1 | Protein Kinase Inhibitor H-8 |